Introduction
Several specific peptides have been found in the gut either in nerves or in special endocrine cells dispersed among the epithelial cells in the deeper crypt layers of the mucosa (Pearse et al. 1977; Said 1984) . Many of these peptides do not as yet have established physiologic functions. Both humans and animals have been found to secrete putative hormones which inhibit (enterochalone) or enhance (enterooxyntin) gastric acid secretion. In experiments with the isolated perfused canine jejunum it has been demonstrated that a potent gastric acid secretogogue is released into the medium (Walker et al. 1983 ). This agent acts both through a Ca ++ dependent and histamine H 2 receptor pathway (Strodel et al. 1985) .
We recently reported on the isolation and purification of a 13,000 dalton (Mr) peptide from pig ileal mucosa tentatively named porcine ileal polypeptide (PIP) (Wider et al. 1984) . The isolated peptide stimulates oxyntic cell hydroxyl ion production in sections of guinea pig gastric fundus in vitro in concentrations in the range of 10-15_ 10-9 M and is thus a potent enterooxyntin. The purpose of this work Supported in part by a grant from the NIH AM-27077 and the Sinai Hospital General Research Fund Offprint requests shouM be sent to: Aaron I. Vinik, M.D., University of Michigan Medical Center, Room B2922 Taubman Health Care Center, Box 046, 1405 E. Ann Street, Ann Arbor, MI 48109, USA was to study the distribution of PIP in different tissues with special attention to the gastrointestinal tract in an effort to clarity its biologic function.
Material and methods
Specimens. Tissue samples from salivary glands, esophagus, stomach, duodenum, upper and lower jejunum, upper, mid and lower ileum, proximal, mid and distal colon were taken from a 3-month old pig (16 kg) under pentobarbital anesthesia. Samples from heart, lung, diaphragm, liver, gallbladder, sciatic nerve, vagal nerve, skeletal muscle, pancreas, spleen, adrenal gland, kidney, ureter, urinary bladder and skin were also harvested. All samples were collected in phosphate-buffered, 10% formalin, and the paraffin embedded tissue sections were used for immunohistochemical staining.
Immunohistochemistry. Endogenous peroxidase was inhibited by incubation of the slides with equal parts of absolute methanol and 3% H202 for 10 rain. This was followed by a 10-min incubation with normal goat serum diluted 1:20 to reduce nonspecific background staining. All dilutions were made with a phosphate buffer (0.05 tool/l) containing NaC1 (0.15 mol/1), bovine serum albumen (40 g/l) and normal goat serum (1% v:v) at pH 7.4. A polyclonal monospecific rabbit anti-PIP serum (APS 53) was used. Antibody specificity was checked by immunoelectrophoresis in agarose and showed only a single precipitation line against crude pig ileal extract. The tissue sections were incubated for 2-3 h at room temperature with this antiserum diluted 1:5,000-1:40,000. A biotinylated goat anti-rabbit IgG antiserum and an Avidin peroxidase complex, both obtained from Vector (Vectastain) were used according to the manufacturer's instructions. The substrate, 3-Y-diaminobenzidine tetrahydrochloride (0.4 g/l, in 0.05 mol/1 phosphate buffer, containing NaC1, 0.15 mol/1 and H20 z 0.05% at pH 7.4) from (Sigma Chemical Company St. Louis Mo) was used for development of the color complex of the immune precipitate. The slides were then counterstained with hematoxylin (Gill No 3 Sigma Chemical Co.) Specificity of staining was determined by immune neutralization using fragment B, the largest fragment of PIP obtained following cyanogen bromide treatment of the native peptide (Wider et al. 1984) . The antiserum, diluted 1:10,000, was incubated with fragment B in three different concentrations 5, 50, and 500 ng/ml for 48 h at + 4 C before application to the sections.
Tissue extractions. The distribution of PIP in the gastrointestinal tract was further evaluated by tissue extraction followed by radioimmunoassay. The entire GI tract was obtained from two pigs at the local abbatoir at the time of slaughter. The mucosa was scraped from the fundus, corpus, and the antrum of the stomach, duodenum and from 30 cm sections of small intestine taken every 60 cm from duodenum to the ileocecal valve. Samples of mucosa were taken from the proximal, mid and distal colon as weIl. The mucosa was homogenized in 20 ml of 0.05 M NH4HCO3 containing benzamidine hydrochloride 0.001 mol/1 and EDTA, 0.01 mol/l pH 8.6 in a Waring blender, followed by 20 strokes in a Dounce homogenizer. The homogenate was centrifuged at 10,000 rpm for 30 min at +4~ and the pH of the supernatant was adjusted to 4.5 with HC1. A precipitate formed and was removed by centrifugation at 10,000 rpm for 30 min at +4 ~ C. The pH of the supernatant was adjusted to 8.6 with NH4OH and aliquots of each sample were diluted 1 : 1,000 in Verona1 buffer pH 8.6. The samples were stored at -20 ~ C until assayed.
The urinary bladders from two pigs were frozen on solid CO2, pulverized in a Waring blender and homogenized in the NH4HCO3 buffer described above. The homogenate was then centrifuged at 10,000 rpm for 30 rain at +4 ~ C and the supernatant was stored at -20 ~ C until further assayed.
Gel filtration experiments. Gel filtration of extracts of iIeal and bladder mucosa were performed on a Sephadex G 50 Fine (1,5 x 90 cm) eluted with a NH4HCOB buffer (0.05 mol/1) containing benzamidine hydrochloride 0.001 tool/1 at +4 ~ C. The column was standardized before and after each run with Blue dextran, 125I-PIP and ribonuclease. An internal standard of 125I-PIP was run with each sample.
Radioimmunoassay. All samples from the extraction procedures and columns were assayed for immunoreactive PIP (IRPIP) using a radioimmunoassay as described previously (Wider et al. 1986) . Essentially the assay is incubated in a barbital buffer, pH 8.6 using a second antibody for separation of bound and free labeled PIP. The assay has a detection limit of 0.5 ng/ml and a sensitivity of 0.1 ng/ml. The intra-assay variation coefficient for samples in the sensitive range was 5% and all samples from single experiments were assayed simultaneously.
Results

Immunohistochemistry
In the gastrointestinal tract immunoreactive PIP (IRPIP) was mainly found immunohistochemically in the distal small intestine. In the proximal ileum IRPIP was confined within scattered single cells in the superficial mucosa (Fig. 1) . In the distal ileum all superficial enterocytes except for goblet cells stained for IRPIP (Fig. 2) . No cells in the deeper layers of the musosa or in the crypts were stained.
No IRPIP was found in heart, lung, diaphragm, liver, gallbladder, sciatic nerve, vagal nerve, skeletal muscle, pancreas, spleen, adrenal gland, kidney or skin using these antibody concentrations. In the urinary tract however IRPIP was seen in the mucosa of the ureter and the urinary bladder. In the bladder the staining was seen throughout the mucosa (Fig. 3) except for the most superficial cuticule. In the ureter only occasional cells scattered in the deeper layers of the mucosa stained for IRPIP (Fig. 4) .
While the ileal mucosa stained intensly with antibody dilutions of 1 : 40,000 -1 : 20,000, these antibody concentrations gave no or, barely visible staining of the mucosa of the urinary tract. For intense staining in the urinary tract higher antibody concentrations of 1 : 10,000-1 : 15,000 had to be used. This could be done without appearance of any visible background staining.
Preincubating the antibody diluted 1 : 10,000, with fragment B of PIP in a concentration of 5 ng/ml or more, completely blocked staining of the urinary tract mucosa. Addition of 5 and 50 ng/ml of fragment B decreased staining of the ileal mucosa while 500 ng/ml was needed to completely block all staining in the ileal mucosa.
Tissue extractions
The distribution of extractable IRPIP in the GI tract is shown in Fig. 5 together with the extractable amounts of IRPIP from whole urinary bladder tissue and skeletal muscle. The highest concentration of PIP was found in the ileal mucosa with negligable amounts in the proximal small intestine, large bowel and urinary bladder. No IRPIP was detected in gastric mucosa or skeletal muscle.
Gel filtration of extracts from urinary bladder and ileal mucosa demonstrated a single peak of IRPIP from both extracts eluting coincident with the 125I-PIP run as internal standard (Fig. 6 ).
Discussion
In this study we have shown that PIP immunoreactivity is uniquely distributed in the mucosa of the distal small intestine and to some extent in the mucosa of the urinary tract. The higher concentration of antibody needed for staining of IRPIP in the bladder mucosa may be due to crossreaction between two antigenically similar proteins, to the presence of a smaller amount of PIP in the urinary tract mucosa or technical differences in the immunohistochemical studies in the two types of tissues. That the differences in relate to concentrations within the tissues is favoured by the extraction data showing low concentrations of IRPIP in the urinary bladder and by the gel filtration studies showing immunoreactive peptides of identical elution volumes in ileal and bladder mucosa.
A cyanogen bromide generated fragment "B" was used for the immune neutralization studies to insure that blocking was due to PIP alone. This fragment contained the immunoreactive portion of the PIP molecule. It would be expected that any contaminating peptides in the isolated PIP preparation would not yield a fragment identical to PIP. Fragment B has a Mr only slightly smaller than PIP and was indeed capable of neutralizing staining in both ileum and bladder. PIP is thus mainly localized to the distal 20% of the small intestine with trace amounts observed in the urinary tract mucosa. The peptide has been identified in the circulation (Wider and Duhaime 1985 a) and causes potent stimulation of gastric acid secretion, both in vitro and in vivo (Wider et al. 1984; Wider et al. 1986 ). This activity suggests an endocrine function of PIP, however, the superficial and especially the distal diffuse localization in ileum contrasts significantly with the localization of other gastrointestinal peptide hormones reported so far. Gut endocrine cells in the small intestine are more scattered among the epithelial lining of the intestinal crypts and to some extent also the basal parts of the villi (Pearse et al. 1977; E1-Salhy et al. 1983; Buffa etal. 1978 Buffa etal. , 1979 Cristina etal. 1978; Lehy et al. 1980; Solcia et al. 1980 ).
The relationship between the different pools of PIP in ileal mucosa, bladder mucosa and plasma can only be speculated upon. The bulk of PIP in the body is evidently localized to the ileal mucosa. The majority of the plasma PIP is thus probably derived from this pool. The presence of small amounts of PIP in the urinary tract mucosa is puzzling. This is however not the only example of two distinct tissue types containing the same immunospecific protein (Heitz et al. 1978 ) but may reflect a general function of PIP in for example mucosal protection or mucosal absorption. It should however be noted that PIP is absent in the mucous cells of the intestinal mucosa.
The results in this report are difficult to interpret in light of the biologic activity studies, It seems unlikely that the stimulatory effect on parietal cell function of this peptide shown earlier in vivo and in vitro should be due to contaminating peptides since PIP is active at very low concentrations (10-15-10-9 mol/1). It is possible that PIP functions in the transport of a nutrient or of bile acids and that it provides a feedback signal to regulate gastric acidity as well. Itch et al. (1979) have demonstrated that the peak acidity of the duodenum is reached at 8-12 h postprandially and drops to neutrality after 16 h. This time interval corresponds to the time interval after eating when the terminal small intestine receives and eliminates chyme. Thus PIP derived from the ileum could function as an enterooxyntin a humeral factor derived from the ileum which has gastric acid secretory properties (Orlloff et al. 1980; Vagne 1980) . The role of the peptide as an enterooxyntin requires further elucidation.
Regardless of the biological function of PIP the clinical implications of a specific ileal peptide are many. An assay for the corresponding human ileal peptide would be of interest in different small bowel diseases and for assesment of small bowel integrity and function.
